CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Miltenyi Biotec against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Quantitative Dna-Based Imaging And Super-Resolution ImagingPRESIDENT AND FELLOWS OF HARVARD COLLEGESep 8, 2023
Point-Of-Care And/Or Portable Platform For Gene TherapyFRED HUTCHINSON CANCER RESEARCH CENTERFeb 1, 2022
CellAUTOLUSApr 8, 2020
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019
Method Of Reversibly Staining A Target CellIBAFeb 1, 2019
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 9, 2018
Use Of An Antibody Directed Against A Membrane ProteinLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESFeb 9, 2018

Explore Miltenyi Biotec's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 2, 2019Method For Automated Generation Of Genetically Modified T Cells3
Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases1

Top competitors of Miltenyi Biotec

List of top competitors of Miltenyi Biotec based on patent oppositions.